IL37 and colorectal carcinoma: Importantly, IL-37 expression in CRC tumors was found (a) to be linearly correlated with their stage, with the highest expression detected in stage I and the lowest in stage IV tumors; and (b) to be associated with survival rates, with higher levels predicting longer disease-free (DFS) and overall (OS) survival [25].